Amphiphilic PEGylated Lanthanide-Doped Upconversion Nanoparticles for Significantly Passive Accumulation in the Peritoneal Metastatic Carcinomatosis Models Following Intraperitoneal Administration.
暂无分享,去创建一个
Wei Feng | Chunhui Huang | Fuyou Li | Yilin Gao | Lang Liu | Bin Shen | Xiao-feng Chen | Li Wang | Liya Wang
[1] Laure Dumont,et al. Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles. , 2015, Journal of biomedical nanotechnology.
[2] Wei Feng,et al. Core-shell Fe3O4@NaLuF4:Yb,Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. , 2012, Biomaterials.
[4] R. Steinhardt,et al. Surface Coating of Nanoparticles Reduces Background Inflammatory Activity while Increasing Particle Uptake and Delivery. , 2017, ACS biomaterials science & engineering.
[5] Ling Li,et al. Improving Anti-Tumor Activity of Curcumin by Polymeric Micelles in Thermosensitive Hydrogel System in Colorectal Peritoneal Carcinomatosis Model. , 2015, Journal of biomedical nanotechnology.
[6] V. Herrera,et al. Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[7] Yang Yang,et al. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. , 2010, Biomaterials.
[8] S. Gambhir,et al. Nanomaterials for In Vivo Imaging. , 2017, Chemical reviews.
[9] Scott H. Medina,et al. Targeting Hepatic Cancer Cells with PEGylated Dendrimers Displaying N‐Acetylgalactosamine and SP94 Peptide Ligands , 2013, Advanced healthcare materials.
[10] David F. Williams,et al. Biocompatibility Pathways: Biomaterials-Induced Sterile Inflammation, Mechanotransduction, and Principles of Biocompatibility Control. , 2017, ACS biomaterials science & engineering.
[11] Chunshui Yu,et al. Green and facile synthesis of a theranostic nanoprobe with intrinsic biosafety and targeting abilities. , 2016, Nanoscale.
[12] M. Morgan,et al. Principles and practice of intraperitoneal chemotherapy for ovarian cancer , 2006, International Journal of Gynecologic Cancer.
[13] S. Dasari,et al. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis. , 2017, Kidney international.
[14] J. Zhao,et al. Lanthanide upconversion luminescence at the nanoscale: fundamentals and optical properties. , 2016, Nanoscale.
[15] T. Akiba,et al. Impact of fluvastatin on hyperlipidemia after renal transplantation. , 2004, Transplantation proceedings.
[16] Wei Feng,et al. Biodistribution of sub-10 nm PEG-modified radioactive/upconversion nanoparticles. , 2013, Biomaterials.
[17] Joseph W. Nichols,et al. Odyssey of a cancer nanoparticle: from injection site to site of action. , 2012, Nano today.
[18] J. Kinoshita,et al. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer. , 2014, Oncology reports.
[19] Mauro Ferrari,et al. Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.
[20] B. Wang,et al. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. , 2011, Toxicology letters.
[21] E. Ruoslahti,et al. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes. , 2016, Biomaterials.
[22] Brian K. Wilson,et al. Real-Time and Multiplexed Photoacoustic Imaging of Internally Normalized Mixed-Targeted Nanoparticles. , 2017, ACS biomaterials science & engineering.
[23] J. Au,et al. Intraperitoneal therapy for peritoneal cancer. , 2010, Future oncology.
[24] A Paul Alivisatos,et al. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. , 2006, Nano letters.
[25] C. Soto,et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. , 2010, Biochemical and biophysical research communications.
[26] Biqiong Chen,et al. Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity. , 2017, Small.
[27] Yujie Xiong,et al. Modification of NaYF4:Yb,Er@SiO2 Nanoparticles with Gold Nanocrystals for Tunable Green-to-Red Upconversion Emissions , 2011 .
[28] Yuan Gao,et al. Water-soluble NaYF4:Yb/Er upconversion nanophosphors: Synthesis, characteristics and application in bioimaging , 2010 .
[29] R. Zhuo,et al. Multifunctional Nanotherapeutics with All-in-One Nanoentrapment of Drug/Gene/Inorganic Nanoparticle. , 2016, ACS applied materials & interfaces.
[30] Sandra N. Ekdawi,et al. Development of a liposome formulation for improved biodistribution and tumor accumulation of pentamidine for oncology applications. , 2015, International journal of pharmaceutics.
[31] Brandon Da Silva,et al. Intra-arterial infusion of PEGylated upconversion nanophosphors to improve the initial uptake by tumors in vivo , 2014 .
[32] Juanjuan Peng,et al. Near‐Infrared Photoregulated Drug Release in Living Tumor Tissue via Yolk‐Shell Upconversion Nanocages , 2014 .
[33] D. Xing,et al. In Vivo Near-Infrared Photodynamic Therapy Based on Targeted Upconversion Nanoparticles. , 2015, Journal of biomedical nanotechnology.
[34] M. Ozmen,et al. Subacute toxicity of uranyl acetate in Swiss-Albino mice. , 1998, Environmental toxicology and pharmacology.
[35] Wei Feng,et al. Upconversion luminescent materials: advances and applications. , 2015, Chemical reviews.
[36] Xiaoyang Xu,et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.
[37] H. Dai,et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. , 2009, Journal of the American Chemical Society.
[38] Hua Tang,et al. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[39] Pei-Xun Liu,et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes , 2010, International journal of nanomedicine.
[40] Thomas Nann,et al. A four-color colloidal multiplexing nanoparticle system. , 2008, ACS nano.
[41] Nitish Thakor,et al. Size and Shell Effects on the Photoacoustic and Luminescence Properties of Dual Modal Rare-Earth-Doped Nanoparticles for Infrared Photoacoustic Imaging. , 2016, ACS biomaterials science & engineering.
[42] Ze Lu,et al. Effects of Carrier on Disposition and Antitumor Activity of Intraperitoneal Paclitaxel , 2007, Pharmaceutical Research.
[43] Yunxin Liu,et al. Upconversion luminescence turning of NaREF4 (RE=0.4Y+0.4La+0.2 (Yb, Er, Tm)) nanoparticles and their applications for detecting Rhodamine B in shrimp , 2017 .
[44] Stephen Clarke,et al. Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics , 2012, Clinical Pharmacokinetics.
[45] G. Nowak,et al. The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies , 2015, Pharmacological reports : PR.
[46] Yuliang Zhao,et al. Biodistribution, excretion, and toxicity of polyethyleneimine modified NaYF4:Yb,Er upconversion nanoparticles in mice via different administration routes. , 2017, Nanoscale.
[47] Qian Liu,et al. Multifunctional rare-earth self-assembled nanosystem for tri-modal upconversion luminescence /fluorescence /positron emission tomography imaging. , 2011, Biomaterials.
[48] Jiwon Bang,et al. Surface engineering of inorganic nanoparticles for imaging and therapy. , 2013, Advanced drug delivery reviews.
[49] Wei Feng,et al. In vivo biodistribution and toxicity assessment of triplet-triplet annihilation-based upconversion nanocapsules. , 2017, Biomaterials.
[50] Wei Feng,et al. Sub-10 nm hexagonal lanthanide-doped NaLuF4 upconversion nanocrystals for sensitive bioimaging in vivo. , 2011, Journal of the American Chemical Society.
[51] S. Sivakumar,et al. Targeted Stealth Polymer Capsules Encapsulating Ln3+-Doped LaVO4 Nanoparticles for Bioimaging Applications. , 2016, ACS biomaterials science & engineering.
[52] Feuser Paulo Emilio,et al. In Vitro Cytotoxicity of Poly(Methyl Methacrylate) Nanoparticles and Nanocapsules Obtained by Miniemulsion Polymerization for Drug Delivery Application , 2016 .
[53] Sumaira Ashraf,et al. In vivo degeneration and the fate of inorganic nanoparticles. , 2016, Chemical Society reviews.
[54] T. Hyeon,et al. Recent Advances in Inorganic Nanoparticle-Based NIR Luminescence Imaging: Semiconductor Nanoparticles and Lanthanide Nanoparticles. , 2017, Bioconjugate chemistry.
[55] S. Spiegel,et al. Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis. , 2016, The Journal of surgical research.
[56] E. Reimhult,et al. Interaction of Size-Tailored PEGylated Iron Oxide Nanoparticles with Lipid Membranes and Cells. , 2017, ACS biomaterials science & engineering.
[57] Tiago Morais,et al. Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[58] S. D. De Smedt,et al. Nanomedicine‐based intraperitoneal therapy for the treatment of peritoneal carcinomatosis — Mission possible?☆ , 2017, Advanced drug delivery reviews.
[59] Kai Yang,et al. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. , 2011, ACS nano.